23840908|t|A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1beta, [corrected] TNF-alpha and IL-6 challenges in C57BL/6 mice.
23840908|a|It is increasingly clear that systemic inflammation has both adaptive and deleterious effects on the brain. However, detailed comparisons of brain effects of systemic challenges with different pro-inflammatory cytokines are lacking. In the present study, we challenged female C57BL/6 mice intraperitoneally with LPS (100 microg/kg), IL-1beta (15 or 50 microg/kg), TNF-alpha (50 or 250 microg/kg) or IL-6 (50 or 125 microg/kg). We investigated effects on core body temperature, open field activity and plasma levels of inflammatory markers at 2 hours post injection. We also examined levels of hepatic, hypothalamic and hippocampal inflammatory cytokine transcripts. Hypothermia and locomotor hypoactivity were induced by LPS>IL-1beta>TNF-alpha>>IL-6. Systemic LPS, IL-1beta and TNF-alpha challenges induced robust and broadly similar systemic and central inflammation compared to IL-6, which showed limited effects, but did induce a hepatic acute phase response. Important exceptions included IFNbeta, which could only be induced by LPS. Systemic IL-1beta could not induce significant blood TNF-alpha, but induced CNS TNF-alpha mRNA, while systemic TNF-alpha could induce IL-1beta in blood and brain. Differences between IL-1beta and TNF-alpha-induced hippocampal profiles, specifically for IL-6 and CXCL1 prompted a temporal analysis of systemic and central responses at 1, 2, 4, 8 and 24 hours, which revealed that IL-1beta and TNF-alpha both induced the chemokines CXCL1 and CCL2 but only IL-1beta induced the pentraxin PTX3. Expression of COX-2, CXCL1 and CCL2, with nuclear localisation of the p65 subunit of NFkappaB, in the cerebrovasculature was demonstrated by immunohistochemistry. Furthermore, we used cFOS immunohistochemistry to show that LPS, IL-1beta and to a lesser degree, TNF-alpha activated the central nucleus of the amygdala. Given the increasing attention in the clinical literautre on correlating specific systemic inflammatory mediators with neurological or neuropsychiatric conditions and complications, these data will provide a useful resource on the likely CNS inflammatory profiles resulting from systemic elevation of particular cytokines. 
23840908	68	71	LPS	Chemical	MESH:D008070
23840908	73	81	IL-1beta	Gene	16176
23840908	95	104	TNF-alpha	Gene	21926
23840908	109	113	IL-6	Gene	16193
23840908	128	135	C57BL/6	CellLine	CVCL:C0MU
23840908	136	140	mice	Species	10090
23840908	181	193	inflammation	Disease	MESH:D007249
23840908	339	351	inflammatory	Disease	MESH:D007249
23840908	418	425	C57BL/6	CellLine	CVCL:C0MU
23840908	426	430	mice	Species	10090
23840908	454	457	LPS	Chemical	MESH:D008070
23840908	475	483	IL-1beta	Gene	16176
23840908	506	515	TNF-alpha	Gene	21926
23840908	541	545	IL-6	Gene	16193
23840908	660	672	inflammatory	Disease	MESH:D007249
23840908	773	785	inflammatory	Disease	MESH:D007249
23840908	808	819	Hypothermia	Disease	MESH:D007035
23840908	824	846	locomotor hypoactivity	Disease	MESH:D009069
23840908	863	866	LPS	Chemical	MESH:D008070
23840908	867	875	IL-1beta	Gene	16176
23840908	876	885	TNF-alpha	Gene	21926
23840908	887	891	IL-6	Gene	16193
23840908	902	905	LPS	Chemical	MESH:D008070
23840908	907	915	IL-1beta	Gene	16176
23840908	920	929	TNF-alpha	Gene	21926
23840908	997	1009	inflammation	Disease	MESH:D007249
23840908	1022	1026	IL-6	Gene	16193
23840908	1135	1142	IFNbeta	Gene	15977
23840908	1175	1178	LPS	Chemical	MESH:D008070
23840908	1189	1197	IL-1beta	Gene	16176
23840908	1233	1242	TNF-alpha	Gene	21926
23840908	1260	1269	TNF-alpha	Gene	21926
23840908	1291	1300	TNF-alpha	Gene	21926
23840908	1314	1322	IL-1beta	Gene	16176
23840908	1363	1371	IL-1beta	Gene	16176
23840908	1376	1385	TNF-alpha	Gene	21926
23840908	1433	1437	IL-6	Gene	16193
23840908	1442	1447	CXCL1	Gene	14825
23840908	1559	1567	IL-1beta	Gene	16176
23840908	1572	1581	TNF-alpha	Gene	21926
23840908	1610	1615	CXCL1	Gene	14825
23840908	1620	1624	CCL2	Gene	20296
23840908	1634	1642	IL-1beta	Gene	16176
23840908	1655	1664	pentraxin	Chemical	-
23840908	1685	1690	COX-2	Gene	17709
23840908	1692	1697	CXCL1	Gene	14825
23840908	1702	1706	CCL2	Gene	20296
23840908	1855	1859	cFOS	Gene	14281
23840908	1894	1897	LPS	Chemical	MESH:D008070
23840908	1899	1907	IL-1beta	Gene	16176
23840908	1932	1941	TNF-alpha	Gene	21926
23840908	2080	2092	inflammatory	Disease	MESH:D007249
23840908	2108	2151	neurological or neuropsychiatric conditions	Disease	MESH:D019636
23840908	2231	2243	inflammatory	Disease	MESH:D007249
23840908	Positive_Correlation	MESH:D009069	16176
23840908	Positive_Correlation	14825	21926
23840908	Positive_Correlation	MESH:D008070	MESH:D007035
23840908	Positive_Correlation	MESH:D008070	MESH:D009069
23840908	Positive_Correlation	MESH:D009069	16193
23840908	Positive_Correlation	16176	20296
23840908	Positive_Correlation	MESH:D009069	21926
23840908	Positive_Correlation	20296	21926
23840908	Positive_Correlation	14825	16176
23840908	Positive_Correlation	MESH:D007249	16176
23840908	Positive_Correlation	MESH:D007035	16176
23840908	Positive_Correlation	MESH:D007035	16193
23840908	Positive_Correlation	MESH:D007249	21926
23840908	Positive_Correlation	MESH:D008070	MESH:D007249
23840908	Positive_Correlation	MESH:D007035	21926
23840908	Positive_Correlation	MESH:D008070	15977

